#AIEye
#Podcast 529: C3 AI (NYSE: $AI) Announces Strategic Alliance with Infor and
Eros (NYSE: $ESGC) Now Collaborating with Google (NasdaqGS: $GOOG) Cloud for #AI
#Tech
Global
#AI in #Pharma to Reach $1.27 Billion in 2021
Point Roberts WA, Vancouver BC – March 8, 2021 – Investorideas.com (www.investorideas.com), a global investor news source covering
Artificial Intelligence (AI) brings you today’s edition of The
AI Eye- watching stock news, deal
tracker and advancements in artificial intelligence.
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2021/030821-AI-Eye.mp3
Read
this in full at https://www.investorideas.com/news/2021/artificial-intelligence/03081AI-ESGC-GOOG.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (NYSE:AI) (NYSE:ESGC) (NasdaqGS:GOOG)
C3.ai, inc. (NYSE:AI)
has announced a strategic alliance with business
cloud software firm Infor to expand enterprise-class AI solutions across
applicable industries to extend the latter’s native machine learning
capabilities. According to the press release, Infor “plans to market, license,
and deploy C3 AI prebuilt solutions,” and both companies intend to “collaborate
on new integrated enterprise AI applications that can support specific industry
needs.” C3 AI CEO Thomas M. Siebel said:
"Infor
provides the enterprise resource planning, supply chain expertise, and data
platform, while C3 AI brings the open, model-driven architecture of the C3 AI
Suite that can reduce the time, complexity, and cost of developing and
deploying enterprise-scale AI applications. This alliance is perfectly
positioned to fast-track the delivery of scalable, industry-specific enterprise
AI solutions. We believe the Infor and C3 AI alliance will provide a useful and
robust complement for thousands of customers and prospects.”
Eros Now, the Indian OTT platform division of global
entertainment company Eros STX Global Corporation (NYSE:ESGC),
is collaborating with Google Cloud (NasdaqGS:GOOG) to “use its Artificial
Intelligence (AI) technology for streaming the entire range of Eros Now movies
and originals with automated subtitles.” Ali Hussein, CEO of Eros Now,
commented:
"Eros
has always been a pioneer in adopting technology to satiate the demands of
audiences and build a deeper connection with them by offering unlimited
entertainment. The innovative use of artificial intelligence and machine
learning will give customized subtitled content for the global audience,
allowing us to target a wider set of subscribers and drive engagement across
Eros Now’ rich consumer offering."
Global
AI in Pharma to Reach $1.27 Billion in 2021
Research published by ReportLinker finds that the global AI in Pharma
market is expected to grow from $0.91 billion in 2020 to $1.27 billion in 2021
with a compound annual growth rate (CAGR) of 39 percent. An excerpt from the
report’s summary outlines the beneficial role played by AI in clinical trials:
The
growing adoption of artificial intelligence (AI) for clinical trials research
is driving its demand in the pharmaceutical market. To bring a new drug to the
market takes on average 10–15 years, and half of this time is consumed during the
clinical trial phases of the drug development cycle.
Hence,
using AI models and analytics tools can accelerate the clinical trial phases,
perception of diseases, identify suitable cases and key investigators to inform
site selection, and support novel clinical study designs.
Sam Mowers, Investorideas.com
Read and hear
other editions of the AI Eye
For a list of
artificial intelligence stocks on Investorideas.com visit here
Investors can
trade these stocks and other ideas on
our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.
About Investorideas.com - News that Inspires Big
Investing Ideas Investorideas.com is a recognized news source publishing third party
news, research and original financial content. Learn about investing in stocks
and sector trends with our news alerts, articles, podcasts and videos,
looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas Potcasts Cannabis News
and Stocks on the Move podcast and column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
The Investorideas.com podcasts are also available on
iTunes ( Apple Podcasts) , Audible ,
Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and
most audio platforms available.
Visit the Podcast
page at Investorideas.com:
https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye-
Watching stock news, deal tracker and advancements in artificial
intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact
Investorideas.com
800 665 0411
Get more Technology stock investor
ideas - news, articles, podcasts and stock directories
No comments:
Post a Comment